TIMER2.0 for analysis of tumor-infiltrating immune cells
Abstract Tumor progression and the efficacy of immunotherapy are strongly influenced by the composition and abundance of immune cells in the tumor microenvironment. Due to the l...
Publications
2 shownSignatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we ...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 10,527
- Institution
- Shanghai Pulmonary Hospital
External Links
Identifiers
- ORCID
- 0000-0002-4028-3661
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.